Drug Search Results
More Filters [+]

ICAM-1

Alternative Names: icam-1
Latest Update: 2024-05-15
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: Subcutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: National Cancer Institute (NCI)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ICAM-1

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

EDIPE

N/A

Not yet recruiting

Hypertension|Pregnancy Outcomes|Pre-Eclampsia

2026-05-01

ChiCTR1900027080

N/A

Recruiting

GNE Myopathy|Ventricular Dysfunction, Left|Diabetes Complications|Coronary Disease|Heart Failure, Diastolic|Hypertension|Dyspnea|Heart Failure, Systolic|Heart Failure, Chronic

2022-12-31

Recent News Events